SOURCE: Applied Visual Sciences
HERNDON, VA–(Marketwire – October 25, 2010) – Applied Visual Sciences (
A key competitive advantage of APVS’s image analysis process is Image Transformation Divergence, with its ability to accurately distinguish between targeted image objects, such as threats or disease states, and other objects that are non-threatening or benign. Typically, many different types of objects in an image have “identically appearing” properties. This is the single-most-important factor responsible for failures in automatic image analysis and detection algorithms. APVS’s Image Transformation Divergence, together with other advanced image analysis processes defined in the patent, dramatically and substantially reduces these “false positive” rates.
The patented process is capable of detecting objects of interest with a high degree of confidence; does not rely only on prior knowledge of an object’s shape, volume, texture or density to be effective; and is most powerful where the presence of disease or threat objects must be distinguished from healthy tissue or non-threat objects that are similar in color, brightness, and texture.
“This patent is yet another step in establishing the credibility of our intellectual property portfolio and protecting our proprietary technology platform for future applications development,” states Bill Donovan, APVS’s President and Chief Operating Officer. “We now have three patents and expect to receive a couple more over the next several weeks. It is our intention to continue to build on our IP portfolio as we anticipate additional patent application filings in the very near future.”
Applied Visual Sciences, Inc.
Applied Visual Sciences, Inc. is the holding company and IT development organization for subsidiaries specializing in high-performance imaging analysis technologies and advanced analytics for automated recognition of targets of interest. Applied Visual Sciences’ subsidiaries include Guardian Technologies International, Inc., a homeland security/defense technology entity, and Signature Mapping Medical Sciences, Inc., a healthcare technology entity. The company is quoted on the OTC Bulletin Board under the symbol APVS.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995:
Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, capital raising activities, trends in the markets, variations in the company’s cash flow, competition, business development efforts, technology availability and cost of materials and other risk factors. Factors that could cause actual results to differ materially are discussed in the Company’s most recent filings with the Securities and Exchange Commission.
For Applied Visual Sciences: